Chronic Pain Clinical Trial
Official title:
Effects of Virtual Reality Motor Control Rehabilitation in Neck Pain Subjects
VR-NECKPAIN is a two-arm, monocentric, single-blind, randomized controlled trial in Neck Pain
patients.
The entire treatment consist in 12 sessions, each during 45 minutes, twice a week for 6
consecutive weeks.
Subjects will be evaluated ad baseline (T0) and after six weeks of rehabilitation (T1). There
will also be a 3 months Follow-Up assessment (T2).
The total duration of study participation for each subject will be approximately 19 weeks,
including evaluation at T0, treatment and evaluation at T1 and T2.
Individuals in the experimental group (VRT) will undergo a virtual reality-based sensorimotor
rehabilitation. Control group (CT) subjects will undergo the same rehabilitation of VR
subjects, in terms of intensity, time and type, but with the virtual reality turned off.
VR-NECKPAIN is a monocentric, single-blind, randomized controlled trial in Neck Pain
patients.
Subjects will receive rehabilitation treatment twice a week, for six consecutive weeks.
Subjects will be evaluated ad baseline (T0) and after six weeks of rehabilitation (T1). Also
there will be a 3 months Follow-Up assessment (T2).
The total duration of study participation for each subject will be approximately 19 weeks,
including evaluation at T0, treatment and evaluation at T1 and T2.
Individuals in the experimental group (VRT) will undergo a virtual reality-based sensorimotor
rehabilitation. Control group (CT) subjects will undergo the same rehabilitation of VR
subjects, in terms of intensity, time and type, but with the virtual reality turned off.
The study is conducted from March 2019 and the conclusion is planned to March 2023.
Patients with Neck Pain will be enrolled at the Department of Rehabilitation and Functional
Recovery of San Raffaele Hospital, via Olgettina 60, Milan.
The treatment will last 45 minutes, 2 sessions per week for a total of 6 weeks. The first 15
minutes of treatment will consist, for each group, in manual therapy treatment, such as
mobilization, manipulation, trigger-points treatment, tailored on the individual.
Subjects in the experimental Group (VRT) will undergo 30 minutes of motor control exercises
using a virtual reality-based sensorimotor rehabilitation provided using the Virtual Reality
Rehabilitation System (VRRS) of Khymeia Group. The equipment includes a computer workstation
connected to a 6 degrees of freedom (DOF) motion-tracking system (Polhemus G4, Vermont, US),
a high-resolution LCD displaying the virtual scenarios on a large screen and a software
processing the motion data coming: from the receiver of the sensors end-effectors placed on
the sternum and on the head through a helmet. The system has been found to reliably record
head position and cervical range of motion among asymptomatic people as well as persistent
neck pain patients.The VRRS allows the participant to perform the requested motor tasks,
while the movement of the system's end-effector is simultaneously represented in a virtual
scenario.
Control Group (CT) subjects will undergo the same treatment of VRT subjects in terms of
intensity, time and type, but with the VR turned off.
In addition, all subjects will be educated in emphasizing self-management and return to
normal function.
A blind assessor will be present in our study. In order to maintain him/her blind, treatments
on patients will never take place in presence of the assessor.
Forty healthy subjects, matched for age and sex to the studied population, will also be
enrolled in order to obtain normative data to compare with neck pain subjects.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
| Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
| Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
| Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
| Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
| Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
| Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
| Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
| Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
| Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
| Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
| Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
| Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
| Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
| Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
| Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
| Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
| Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
| Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|